Skip to main content
. 2024 Jul 4;8(4):384–395. doi: 10.1016/j.mayocpiqo.2024.06.001

Table 3.

Decision to Use BP-Lowering Medications: ACC/AHA COR/LOEa,b

Stage 2 high BP Stage 1 high BP Elevated BP
ASCVD risk ≥10% COR/LOE 1A COR LOE 1A Not recommended
ASCVD risk <10% COR LOE 1 C-LD Not initially recommended Not recommended
a

Abbreviations: ACC, American College of Cardiology; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; COR, class of recommendation; LOE, level of evidence.

b

Nonpharmacologic lifestyle modifications recommended for all (COR LOE 1A). For older adults (65 years or older) with hypertension and a high burden of comorbidity and limited life expectancy, clinical judgment, patient preference, and a team-based approach to assess risk/benefit is reasonable for decisions regarding intensity of BP-lowering and choice of antihypertensive drugs (COR LOEIIa-CEO).